|
|
|
Volumn 49, Issue RR-9, 2000, Pages 1-35
|
|
Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
23 VALENT PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE;
23-VALENT PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE;
BACTERIAL VACCINE;
BACTERIUM ANTIBODY;
HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE;
MENINGOCOCCUS VACCINE;
PNEUMOCOCCUS VACCINE;
VACCINE;
ADULT;
ANTIBIOTIC RESISTANCE;
ARTICLE;
CHILD;
CLASSIFICATION;
COST BENEFIT ANALYSIS;
DRUG EFFECT;
ECONOMICS;
HUMAN;
IMMUNOLOGY;
INFANT;
PRACTICE GUIDELINE;
PRESCHOOL CHILD;
RISK FACTOR;
STANDARD;
STREPTOCOCCUS INFECTION;
STREPTOCOCCUS PNEUMONIAE;
VACCINATION;
ADULT;
ANTIBODIES, BACTERIAL;
BACTERIAL VACCINES;
CHILD;
CHILD, PRESCHOOL;
COST-BENEFIT ANALYSIS;
DRUG RESISTANCE, MICROBIAL;
HUMANS;
INFANT;
MENINGOCOCCAL VACCINES;
PNEUMOCOCCAL INFECTIONS;
PNEUMOCOCCAL VACCINES;
RISK FACTORS;
STREPTOCOCCUS PNEUMONIAE;
VACCINATION;
VACCINES, CONJUGATE;
|
|
EID: 0034612937
PISSN: 10575987
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (738)
|
|
References (0)
|